Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for methyl root_names_name in Any Name (approximate match)

Showing 1311 - 1320 of 34007 results

First page
Previous page
Next page
Next page

GIREDESTRANT

28P3DU6DB3

Search for Structure

Status:

Investigational

Source:

NCT04546009: Phase 3 Interventional Active, not recruiting Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04546009

Class (Stereo):

CHEMICAL (ABSOLUTE)

GSK-232802

AG92SGO434

Search for Structure

Status:

Investigational

Source:

NCT00604825: Phase 2 Interventional Completed Menopausal and Female Climacteric States

(2007)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00604825

Class (Stereo):

CHEMICAL (ACHIRAL)

RALTEGRAVIR F-18

5G8B507W3F

Search for Structure

Status:

Investigational

Source:

NCT03174977: Early Phase 1 Interventional Recruiting HIV-1-infection

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03174977

Class (Stereo):

CHEMICAL (ACHIRAL)

BEVUROGANT

1874HVK11I

Search for Structure

Status:

Investigational

Source:

INN:bevurogant [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/1874HVK11I

Class (Stereo):

CHEMICAL (ABSOLUTE)

ELISMETREP

KIB8V5UR7D

Search for Structure

Status:

Investigational

Source:

NCT03541200: Phase 2 Interventional Completed Vasomotor Symptoms (VMS)

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03541200

Class (Stereo):

CHEMICAL (ACHIRAL)

GLPG-0974

X7REK61AIS

Search for Structure

Status:

Investigational

Source:

NCT01829321: Phase 2 Interventional Completed Ulcerative Colitis

(2013)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01829321

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Free fatty acid receptor 2

Vamotinib

I8C3R768IZ

Search for Structure

Status:

Investigational

Source:

NCT02885766: Phase 1/Phase 2 Interventional Unknown status Chronic Myeloid Leukemia

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02885766

Class (Stereo):

CHEMICAL (ACHIRAL)

RELDESEMTIV

4S0HBYW6QE

Search for Structure

Status:

Investigational

Source:

NCT03160898: Phase 2 Interventional Completed Amyotrophic Lateral Sclerosis

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03160898

Class (Stereo):

CHEMICAL (ABSOLUTE)

VT-1598

AV9K9X720D

Search for Structure

Status:

Investigational

Source:

NCT04208321: Phase 1 Interventional Completed Coccidioidomycosis

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04208321

Class (Stereo):

CHEMICAL (ABSOLUTE)

Emavusertib

MH5DMF9JKY

Search for Structure

Status:

Investigational

Source:

INN:emavusertib [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/MH5DMF9JKY

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Interleukin-1 receptor-associated kinase 4

Structure of GIREDESTRANT

ABSOLUTE

Structure of GSK-232802

ACHIRAL

Structure of RALTEGRAVIR F-18

ACHIRAL

RALTEGRAVIR F-18

Structure of BEVUROGANT

ABSOLUTE

Structure of ELISMETREP

ACHIRAL

Structure of GLPG-0974

ABSOLUTE

Structure of Vamotinib

ACHIRAL

Structure of RELDESEMTIV

ABSOLUTE

Structure of VT-1598

ABSOLUTE

Structure of Emavusertib

ABSOLUTE

Showing 1311 - 1320 of 34007 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1